{"doi":"10.3390/nu13103317","title":"Alcohol Use and the Risk of Communicable Diseases","abstract":"<jats:p>The body of knowledge on alcohol use and communicable diseases has been growing in recent years. Using a narrative review approach, this paper discusses alcohol’s role in the acquisition of and treatment outcomes from four different communicable diseases: these include three conditions included in comparative risk assessments to date—Human Immunodeficiency Virus (HIV)/AIDS, tuberculosis (TB), and lower respiratory infections/pneumonia—as well as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) because of its recent and rapid ascension as a global health concern. Alcohol-attributable TB, HIV, and pneumonia combined were responsible for approximately 360,000 deaths and 13 million disability-adjusted life years lost (DALYs) in 2016, with alcohol-attributable TB deaths and DALYs predominating. There is strong evidence that alcohol is associated with increased incidence of and poorer treatment outcomes from HIV, TB, and pneumonia, via both behavioral and biological mechanisms. Preliminary studies suggest that heavy drinkers and those with alcohol use disorders are at increased risk of COVID-19 infection and severe illness. Aside from HIV research, limited research exists that can guide interventions for addressing alcohol-attributable TB and pneumonia or COVID-19. Implementation of effective individual-level interventions and alcohol control policies as a means of reducing the burden of communicable diseases is recommended.</jats:p>","journal":"Nutrients","year":2021,"id":630602,"datarank":0.6329261557764161,"base_score":4.219507705176107,"endowment":4.219507705176107,"self_citation_contribution":0.6329261557764161,"citation_network_contribution":0.0,"self_endowment_contribution":0.6329261557764161,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":67,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1633699,"name":"Sheela V. Shenoi","orcid":null,"position":1,"is_corresponding":false},{"id":297724,"name":"Paul A. Shuper","orcid":"0000-0001-9033-8598","position":2,"is_corresponding":false},{"id":1633701,"name":"Ronald Scott Braithwaite","orcid":null,"position":3,"is_corresponding":false},{"id":244607,"name":"Jürgen Rehm","orcid":"0000-0001-5665-0385","position":4,"is_corresponding":false},{"id":1060665,"name":"Neo K. Morojele","orcid":"0000-0003-2891-2557","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Alcohol Use and the Risk of Communicable Diseases","abstract":"<jats:p>The body of knowledge on alcohol use and communicable diseases has been growing in recent years. Using a narrative review approach, this paper discusses alcohol’s role in the acquisition of and treatment outcomes from four different communicable diseases: these include three conditions included in comparative risk assessments to date—Human Immunodeficiency Virus (HIV)/AIDS, tuberculosis (TB), and lower respiratory infections/pneumonia—as well as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) because of its recent and rapid ascension as a global health concern. Alcohol-attributable TB, HIV, and pneumonia combined were responsible for approximately 360,000 deaths and 13 million disability-adjusted life years lost (DALYs) in 2016, with alcohol-attributable TB deaths and DALYs predominating. There is strong evidence that alcohol is associated with increased incidence of and poorer treatment outcomes from HIV, TB, and pneumonia, via both behavioral and biological mechanisms. Preliminary studies suggest that heavy drinkers and those with alcohol use disorders are at increased risk of COVID-19 infection and severe illness. Aside from HIV research, limited research exists that can guide interventions for addressing alcohol-attributable TB and pneumonia or COVID-19. Implementation of effective individual-level interventions and alcohol control policies as a means of reducing the burden of communicable diseases is recommended.</jats:p>","is_dataset_classified":null,"base_score":4.219507705176107,"endowment":4.219507705176107,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"34684318","pmcid":"PMC8540096","openalex_id":"https://openalex.org/W3201299689","authors":[],"funders":[{"funder_name":"National Institute on Alcohol Abuse and Alcoholism","grant_id":"1R01AA028009-01A1","title":null},{"funder_name":"National Institute on Alcohol Abuse and Alcoholism","grant_id":"5UH3AA026212-05","title":"Enhancing HIV Pre-Exposure Prophylaxis (PrEP) by Targeting Hazardous Alcohol Use and Concurrent Conditions"},{"funder_name":"National Institute on Alcohol Abuse and Alcoholism","grant_id":"R01AA027481","title":null},{"funder_name":"Canadian Institutes of Health Research","grant_id":"SMN-13950","title":null},{"funder_name":"NIAAA NIH HHS","grant_id":"UH2 AA026212","title":null},{"funder_name":"NIAAA NIH HHS","grant_id":"UH3 AA026212","title":null},{"funder_name":"NCATS NIH HHS","grant_id":"UL1 TR001863","title":null},{"funder_name":"NIAAA NIH HHS","grant_id":"R01 AA028009","title":null},{"funder_name":"National Institutes of Health","grant_id":"5R01AA027481-05","title":"Could long-acting medications facilitate \"ending AIDS by 2030\" in southern Africa? An allocative efficiency analysis"},{"funder_name":"Canadian Institutes of Health Research","grant_id":"unidentified","title":"unidentified"},{"funder_name":"National Institutes of Health","grant_id":"5R01AA028009-03","title":"A microsimulation of alcohol control interventions to advance health equity and reverse the current decrease in life expectancy in the US"}],"total_grants":11,"fwci":6.138,"citation_percentile":0.97444444,"influential_citations":0,"citation_trend":[{"year":2021,"count":2},{"year":2022,"count":8},{"year":2023,"count":18},{"year":2024,"count":15},{"year":2025,"count":14},{"year":2026,"count":10}],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"https://www.mdpi.com/2072-6643/13/10/3317/pdf?version=1632387868","host_type":"journal"},{"url":"https://www.mdpi.com/2072-6643/13/10/3317/pdf?version=1632387868","host_type":"publisher"},{"url":"https://www.mdpi.com/2072-6643/13/10/3317/pdf","host_type":"publisher"},{"url":"https://doi.org/10.3390/nu13103317","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/34684318","host_type":"repository"},{"url":"https://doaj.org/article/8a468512affb46058fb3de49f385a53e","host_type":"repository"},{"url":"https://dx.doi.org/10.3390/nu13103317","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8540096","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC8540096","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC8540096?pdf=render","host_type":"Europe_PMC"},{"url":"http://dx.doi.org/10.3390/nu13103317","host_type":""},{"url":"https://doi.org/https://doi.org/10.3390/nu13103317","host_type":""}],"fields_of_study":["HIV, Drug Use, Sexual Risk","Homelessness and Social Issues","Hepatitis C virus research","03 medical and health sciences","0302 clinical medicine"],"mesh_terms":["Global Burden of Disease","COVID-19","SARS-CoV-2","Alcoholism","Communicable Diseases","Humans","Respiratory Tract Infections","Risk","Tuberculosis","HIV Infections","Comorbidity"],"keywords":["Medicine","Environmental health","Psychological intervention","Pneumonia","Tuberculosis","Intensive care medicine","Psychiatry","Internal medicine","Pathology","Infectious diseases","Alcohol","HIV","Communicable Diseases","Severe Acute Respiratory Syndrome Coronavirus 2","Risk","SARS-CoV-2","COVID-19","HIV Infections","Review","Comorbidity","Global Burden of Disease","Alcoholism","Humans","Respiratory Tract Infections"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"},{"sdg_number":0,"sdg_label":"No poverty"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[{"name":"doi"}],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-05T21:45:04.823893Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}